Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Emerging Trends in Synthetic Drugs Workshop Presentation Slides

Emerging Trends in Synthetic Drugs Workshop Presentation Slides

April 30, 2013

8:30 - 9:00 AM Registration
9:00 - 9:30 AM

WELCOME AND OPENING REMARKS

  • John Paul Jones II, Program Manager, Law Enforcement Standards Program (OLES), National Institute of Standards and Technology (NIST)
  • Jeff Comparin, Laboratory Director, Special Testing & Research Laboratory, Drug Enforcement Administration (DEA)
  • Scott Oulton, Chair of Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) & Associate Deputy Assistant Administrator, Office of Forensic Sciences, DEA
9:30 - 10:15 AM

EMERGING TRENDS IN SYNTHETIC CANNABINOIDS AND SUBSTITUTE CATHINONES

Overview of the Problem (Will Not Be Webcast or Captioned)

  • Bob Bell, Supervisory Special Agent, Office of Diversion Control, DEA
10:15 - 10:30 AM Break
10:30 - 11:45 AM

FEDERAL EMERGING TRENDS

Classes and Structures of Emerging Drugs

  • Arthur Berrier, PhD, Senior Research Chemist, Special Testing & Research Laboratory, DEA

Novel Hallucinogens and Plant-Derived Highs

  • Emily Dye, Forensic Chemist, Special Testing & Research Laboratory, DEA

Control Scheduling and Pending Legislation(Will Not Be Webcast or Captioned)

  • Terry Boos, Chemist, Office of Diversion Control, DEA

Moderated by Shannan Williams, Associate (Contractor), OLES, NIST

11:45 - 12:30 PM

INTERNATIONAL EMERGING TRENDS

New Drugs in the European Union

  • Andrew Cunningham, Scientific Analyst, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
12:30 - 1:45 PM Lunch
1:45 - 3:15 PM

STATE AND LOCAL EMERGING TRENDS - PART ONE

Synthetic Structures, State Legislation, Brand Names, Novel Approaches to Analysis, and How Analytical Results are Reported

3:15 - 3:30 PM Break
3:30 - 4:15 PM

PHARMACOLOGY OF SYNTHETIC DRUGS

  • Marilyn A. Huestis, PhD, Chief, Chemistry and Drug Metabolism, Clinical Pharmacology and Therapeutic Research Branch, National Institutes of Health Biomedical Research Center
4:15 - 5:00 PM

TOXICOLOGICAL ASPECTS OF SYNTHETIC DRUGS

  • Barry Logan, PhD, Executive Director, Center for Forensic Science Research and Education, National Medical Services

May 1, 2013

8:30 - 9:00 AM Registration
9:00 - 9:20 AM

OPENING REMARKS AND CAPABILITIES FOR MEASUREMENTS, MATERIALS, DATA MODELING, AND INFORMATION PROCESSING IN THE CHEMICAL SCIENCES DIVISION

9:20 - 11:00 AM

IDENTIFICATION AND STANDARDS

Criteria for Identification of Synthetic Drugs

  • Scott Oulton, Chair of SWGDRUG & Associate Deputy Assistant Administrator, Office of Forensic Sciences, DEA

SWGDRUG Proposed Recommendation on Analogues and Structural Class Determinations

  • Linda Jackson, Vice Chair of SWGDRUG & Director, Virginia Department of Forensic Science

Validation/Authentication of Physical Standards

  • Nicole Astor, Chemistry Technical Leader, Division of Forensic Sciences, Georgia Bureau of Investigation

Authentication of Physical Standards

  • Roxanne Franckowski, Senior Forensic Chemist, Special Testing & Research Laboratory, DEA

Moderated by John Paul Jones II, Program Manager, OLES, NIST

11:00 - 11:15 AM Break
11:15 - 12:30 PM

COLLABORATIVE EFFORTS

Live Demo of Online Database Resources for the Identification of Novel and Emerging Trends

  • Peter R. Stout, PhD, Senior Research Forensic Scientist, Research Triangle Institute (RTI) International

Advisory Committee for the Evaluation of Controlled Substances Analogs

  • Lindsay Reinhold, Forensic Chemist IV, National Medical Services

Moderated by Karen Phinney, Group Leader, Bioanalytical Science, NIST

12:30 - 1:30 PM Lunch
1:30 - 3:00 PM

STATE AND LOCAL EMERGING TRENDS - PART TWO

Synthetic Structures, State Legislation, Brand Names, Novel Approaches to Analysis, and How Analytical Results are Reported

Moderated by Shannan Williams, Associate (Contractor), OLES, NIST

3:00 - 3:15 PM Break
3:15 - 5:00 PM

LABORATORY ANALYTICAL TECHNIQUES

Color Tests and Analytical Difficulties with Emerging Drugs of Abuse

  • Jeremy Morris, Johnson County, Missouri Crime Laboratory

Statistical Sampling Approaches for Synthetic Drugs

  • Jill Head, Supervisory Chemist, Special Testing & Research Laboratory, DEA

Interpretation and Potential Pitfalls of Analysis

  • Josh Yohannan, Forensic Chemist, Special Testing & Research Laboratory, DEA

DEA Dosing Studies

  • Elizabeth Guest, PhD, Forensic Chemist, Special Testing & Research Laboratory, DEA

Moderated by William MacCrehan, Research Chemist, CSD, NIST

5:00 PM

CLOSING REMARKS

John Paul Jones II, Program Manager, OLES, NIST



Created April 29, 2013, Updated January 9, 2017